NAPCO SECURITY TECHNOLOGIES, INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NAPCO SECURITY TECHNOLOGIES, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $181.62M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $188.82M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $170.00M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $143.59M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $114.04M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $101.36M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $102.93M | May 17, 2022 |
| FY2018 | Jun 30, 2018 | $27.26M | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | $22.20M | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | $21.11M | Sep 13, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $25.68M | Sep 13, 2017 |
| FY2017 | Mar 31, 2017 | $20.81M | Sep 13, 2017 |
| FY2017 | Dec 31, 2016 | $20.72M | Sep 13, 2017 |
| FY2017 | Sep 30, 2016 | $20.17M | Sep 13, 2017 |
| FY2017 | Jun 30, 2016 | $24.06M | Sep 13, 2017 |
| FY2017 | Mar 31, 2016 | $19.81M | Sep 13, 2017 |
| FY2017 | Dec 31, 2015 | $20.50M | Sep 13, 2017 |
| FY2017 | Sep 30, 2015 | $18.15M | Sep 13, 2017 |
| FY2017 | Jun 30, 2015 | $77.76M | Sep 13, 2017 |
| FY2015 | Jun 30, 2014 | $74.38M | Sep 10, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $101.03M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $101.75M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $73.23M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $59.16M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $50.75M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $42.84M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $44.20M | May 17, 2022 |
| FY2018 | Jun 30, 2018 | $12.14M | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | $8.89M | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | $8.48M | Sep 13, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $43.41M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $49.82M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $27.13M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $19.60M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $15.41M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $7.80M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $12.48M | May 17, 2022 |
| FY2018 | Jun 30, 2018 | $3.70M | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | $1.83M | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | $1.23M | Sep 13, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $46.26M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $53.82M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $30.33M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $18.23M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $17.93M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $10.07M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $13.78M | May 17, 2022 |
| FY2018 | Jun 30, 2018 | $4.28M | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | $1.91M | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | $1.17M | Sep 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $12.58M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $10.76M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $9.33M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $8.02M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $7.62M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $7.26M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $7.21M | May 17, 2022 |
| FY2019 | Jun 30, 2018 | $6.63M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $6.72M | Sep 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $42.19M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $37.17M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $33.58M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $32.91M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $25.20M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $23.67M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $23.21M | May 17, 2022 |
| FY2019 | Jun 30, 2018 | $22.95M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $23.20M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $21.26M | Sep 13, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $53.53M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $45.37M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $24.70M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $8.33M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $22.99M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $10.31M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $8.65M | May 17, 2022 |
| FY2019 | Jun 30, 2018 | $7.87M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $2.45M | Sep 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.12M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $1.59M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $2.96M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $1.48M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $1.01M | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | $1.62M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $1.99M | May 17, 2022 |
| FY2019 | Jun 30, 2018 | $1.28M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $1.41M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $693.0K | Sep 13, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $198.14M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $207.75M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $166.65M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $148.58M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $122.55M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $104.50M | May 17, 2022 |
| FY2020 | Jun 30, 2019 | $85.91M | Sep 15, 2020 |
| FY2019 | Jun 30, 2018 | $73.27M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $70.86M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $64.77M | Sep 13, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.54M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $28.86M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $26.49M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $34.79M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $30.16M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $27.96M | May 17, 2022 |
| FY2020 | Jun 30, 2019 | $14.74M | Sep 15, 2020 |
| FY2019 | Jun 30, 2018 | $9.82M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $13.97M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $13.50M | Sep 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $168.61M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $178.89M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $140.17M | Aug 25, 2025 |
| FY2025 | Jun 30, 2022 | $113.79M | Aug 25, 2025 |
| FY2024 | Jun 30, 2021 | $92.39M | Aug 29, 2024 |
| FY2023 | Jun 30, 2020 | $76.54M | Sep 8, 2023 |
| FY2022 | Jun 30, 2019 | $70.54M | Aug 29, 2022 |
| FY2021 | Jun 30, 2018 | $62.56M | May 17, 2022 |
| FY2019 | Jun 30, 2017 | $56.89M | Sep 13, 2019 |
| FY2018 | Jun 30, 2016 | $51.27M | Sep 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $199.08M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $174.30M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $137.74M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $112.91M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $93.31M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $77.90M | May 17, 2022 |
| FY2020 | Jun 30, 2019 | $70.92M | Sep 15, 2020 |
| FY2019 | Jun 30, 2018 | $59.42M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $51.77M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $46.17M | Sep 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $83.08M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $65.34M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $35.96M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $41.73M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | $34.81M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $18.25M | May 17, 2022 |
| FY2020 | Jun 30, 2019 | $8.03M | Sep 15, 2020 |
| FY2019 | Jun 30, 2018 | $5.31M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | $3.45M | Sep 13, 2018 |
| FY2019 | Jun 30, 2016 | $3.45M | Sep 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2021 | $3.90M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $2.11M | May 17, 2022 |
| FY2018 | Jun 30, 2018 | $0 | Sep 13, 2018 |
| FY2017 | Jun 30, 2017 | $3.50M | Sep 13, 2017 |
| FY2016 | Jun 30, 2016 | $4.80M | Sep 8, 2016 |
| FY2016 | Jun 30, 2015 | $10.70M | Sep 8, 2016 |
| FY2015 | Jun 30, 2014 | $11.80M | Sep 10, 2015 |
| FY2014 | Jun 30, 2013 | $16.40M | Sep 15, 2014 |
| FY2013 | Jun 30, 2012 | $20.26M | Sep 17, 2013 |
| FY2012 | Jun 30, 2011 | $23.78M | Sep 21, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | 0 | May 17, 2022 |
| FY2018 | Jun 30, 2018 | 0 | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | 0 | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | 0 | Sep 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | 0 | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | 0 | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Sep 8, 2023 |
| FY2022 | Jun 30, 2020 | 0 | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | 0 | May 17, 2022 |
| FY2018 | Jun 30, 2018 | 0 | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | 0 | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | 0 | Sep 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 35.66M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 36.87M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | 36.77M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | 36.73M | Sep 8, 2023 |
| FY2022 | Jun 30, 2021 | 36.70M | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | 36.69M | May 17, 2022 |
| FY2020 | Jun 30, 2019 | 18.48M | Sep 15, 2020 |
| FY2019 | Jun 30, 2018 | 18.73M | Sep 13, 2019 |
| FY2018 | Jun 30, 2017 | 18.84M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | 18.79M | Sep 13, 2017 |